open access

Vol 67, No 6 (2016)
Original paper
Submitted: 2016-04-09
Accepted: 2016-06-09
Published online: 2016-12-30
Get Citation

Selenium supplementation could restore euthyroidism in subclinical hypothyroid patients with autoimmune thyroiditis

Ilenia Pirola, Elena Gandossi, Barbara Agosti, Andrea Delbarba, Carlo Cappelli
·
Pubmed: 28042649
·
Endokrynol Pol 2016;67(6):567-571.

open access

Vol 67, No 6 (2016)
Original Paper
Submitted: 2016-04-09
Accepted: 2016-06-09
Published online: 2016-12-30

Abstract

Intriduction: The thyroid is an organ with one of the highest selenium concentrations, containing many selenoproteins implicated in thyroid hormone metabolism. Treatment with levothyroxine has been recommended for all subclinical hypothyroid patients with TSH levels > 10 mU/L, whereas for those with TSH< 10 mU/L treatment remains controversial.

Aim: A randomised controlled prospective study was performed to investigate the effects of Se treatment on patients with autoimmune thyroiditis and mild sub-clinical hypothyroidism (TSH < 10 mU/L).

Material and methods: A total of 196 patients with autoimmune thyroiditis were recruited in the study. Patients were assigned to receive (case) or not receive (control) an oral selenomethionine treatment. Cases received 83 mcg selenomethionine/day orally for four months. All the patient’s charts were submitted to thyroid hormonal profile (TSH, fT4) and TPOAb evaluation upon enrolment and at the end of the study.

Results: In total 192 patients completed the study. Cases and controls were superimposable for age, gender, thyroid hormonal profile, and TPOAb levels. At the end of the study, 33/192 (17.2%) participants restored euthyroidism (Responders). Responders were significantly more frequent among Cases than Controls (30/96 [31.3%] vs. 3/96 [3.1%], p < 0.0001).

Conclusion: Selenium supplementation could restore euthyroidism in one third of subclinical hypothyroidism patients with autoimmune thyroiditis. (Endokrynol Pol 2016; 67 (6): 567–571)

Abstract

Intriduction: The thyroid is an organ with one of the highest selenium concentrations, containing many selenoproteins implicated in thyroid hormone metabolism. Treatment with levothyroxine has been recommended for all subclinical hypothyroid patients with TSH levels > 10 mU/L, whereas for those with TSH< 10 mU/L treatment remains controversial.

Aim: A randomised controlled prospective study was performed to investigate the effects of Se treatment on patients with autoimmune thyroiditis and mild sub-clinical hypothyroidism (TSH < 10 mU/L).

Material and methods: A total of 196 patients with autoimmune thyroiditis were recruited in the study. Patients were assigned to receive (case) or not receive (control) an oral selenomethionine treatment. Cases received 83 mcg selenomethionine/day orally for four months. All the patient’s charts were submitted to thyroid hormonal profile (TSH, fT4) and TPOAb evaluation upon enrolment and at the end of the study.

Results: In total 192 patients completed the study. Cases and controls were superimposable for age, gender, thyroid hormonal profile, and TPOAb levels. At the end of the study, 33/192 (17.2%) participants restored euthyroidism (Responders). Responders were significantly more frequent among Cases than Controls (30/96 [31.3%] vs. 3/96 [3.1%], p < 0.0001).

Conclusion: Selenium supplementation could restore euthyroidism in one third of subclinical hypothyroidism patients with autoimmune thyroiditis. (Endokrynol Pol 2016; 67 (6): 567–571)

Get Citation

Keywords

selenium, Hashimoto’s thyroiditis, hypothyroidism, selenoproteins

About this article
Title

Selenium supplementation could restore euthyroidism in subclinical hypothyroid patients with autoimmune thyroiditis

Journal

Endokrynologia Polska

Issue

Vol 67, No 6 (2016)

Article type

Original paper

Pages

567-571

Published online

2016-12-30

Page views

8244

Article views/downloads

7848

DOI

10.5603/EP.2016.0064

Pubmed

28042649

Bibliographic record

Endokrynol Pol 2016;67(6):567-571.

Keywords

selenium
Hashimoto’s thyroiditis
hypothyroidism
selenoproteins

Authors

Ilenia Pirola
Elena Gandossi
Barbara Agosti
Andrea Delbarba
Carlo Cappelli

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl